Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$13.58 - $17.36 $60,118 - $76,852
-4,427 Reduced 10.6%
37,342 $587,000
Q4 2023

Feb 12, 2024

SELL
$10.11 - $16.54 $59,881 - $97,966
-5,923 Reduced 12.42%
41,769 $673,000
Q3 2023

Nov 14, 2023

BUY
$12.46 - $15.48 $27,860 - $34,613
2,236 Added 4.92%
47,692 $606,000
Q2 2023

Aug 14, 2023

SELL
$13.28 - $15.96 $120,980 - $145,395
-9,110 Reduced 16.7%
45,456 $640,000
Q1 2023

May 15, 2023

BUY
$14.26 - $22.1 $223,368 - $346,174
15,664 Added 40.27%
54,566 $843,000
Q4 2022

Feb 14, 2023

SELL
$14.85 - $19.04 $35,446 - $45,448
-2,387 Reduced 5.78%
38,902 $637,000
Q3 2022

Nov 14, 2022

SELL
$12.38 - $20.23 $13,419 - $21,929
-1,084 Reduced 2.56%
41,289 $764,000
Q2 2022

Aug 15, 2022

SELL
$9.11 - $13.98 $648,877 - $995,753
-71,227 Reduced 62.7%
42,373 $557,000
Q1 2022

May 13, 2022

BUY
$6.87 - $11.11 $423,879 - $685,487
61,700 Added 118.88%
113,600 $1.05 Million
Q1 2021

May 17, 2021

SELL
$40.39 - $56.73 $60,585 - $85,095
-1,500 Reduced 2.81%
51,900 $2.33 Million
Q4 2020

Feb 03, 2021

SELL
$51.77 - $66.18 $678,187 - $866,958
-13,100 Reduced 19.7%
53,400 $3.05 Million
Q3 2020

Nov 16, 2020

BUY
$43.8 - $58.16 $223,380 - $296,616
5,100 Added 8.31%
66,500 $3.41 Million
Q2 2020

Aug 12, 2020

BUY
$37.05 - $65.03 $1.14 Million - $2.01 Million
30,900 Added 101.31%
61,400 $3.67 Million
Q1 2020

May 06, 2020

BUY
$33.63 - $69.4 $282,492 - $582,960
8,400 Added 38.01%
30,500 $1.26 Million
Q3 2019

Nov 12, 2019

BUY
$19.95 - $38.85 $201,495 - $392,385
10,100 Added 84.17%
22,100 $750,000
Q2 2019

Aug 14, 2019

BUY
$21.05 - $26.21 $6,315 - $7,863
300 Added 2.56%
12,000 $271,000
Q1 2019

May 13, 2019

BUY
$20.65 - $29.55 $241,604 - $345,735
11,700 New
11,700 $272,000
Q4 2018

Feb 11, 2019

SELL
$19.08 - $36.14 $150,732 - $285,506
-7,900 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$33.57 - $42.1 $265,203 - $332,590
7,900 New
7,900 $306,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.